1. Home
  2. BDX vs CHTR Comparison

BDX vs CHTR Comparison

Compare BDX & CHTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDX
  • CHTR
  • Stock Information
  • Founded
  • BDX 1897
  • CHTR 1993
  • Country
  • BDX United States
  • CHTR United States
  • Employees
  • BDX N/A
  • CHTR N/A
  • Industry
  • BDX Medical/Dental Instruments
  • CHTR Cable & Other Pay Television Services
  • Sector
  • BDX Health Care
  • CHTR Telecommunications
  • Exchange
  • BDX Nasdaq
  • CHTR Nasdaq
  • Market Cap
  • BDX 58.9B
  • CHTR 48.3B
  • IPO Year
  • BDX 1962
  • CHTR 1999
  • Fundamental
  • Price
  • BDX $167.12
  • CHTR $401.73
  • Analyst Decision
  • BDX Buy
  • CHTR Hold
  • Analyst Count
  • BDX 9
  • CHTR 18
  • Target Price
  • BDX $246.88
  • CHTR $398.18
  • AVG Volume (30 Days)
  • BDX 3.5M
  • CHTR 1.4M
  • Earning Date
  • BDX 05-01-2025
  • CHTR 04-25-2025
  • Dividend Yield
  • BDX 2.49%
  • CHTR N/A
  • EPS Growth
  • BDX 14.07
  • CHTR 16.01
  • EPS
  • BDX 5.16
  • CHTR 35.86
  • Revenue
  • BDX $20,867,000,000.00
  • CHTR $55,141,000,000.00
  • Revenue This Year
  • BDX $9.27
  • CHTR $2.10
  • Revenue Next Year
  • BDX $4.98
  • CHTR $1.43
  • P/E Ratio
  • BDX $32.39
  • CHTR $11.20
  • Revenue Growth
  • BDX 5.84
  • CHTR 0.93
  • 52 Week Low
  • BDX $163.33
  • CHTR $261.76
  • 52 Week High
  • BDX $251.99
  • CHTR $415.27
  • Technical
  • Relative Strength Index (RSI)
  • BDX 23.63
  • CHTR 65.28
  • Support Level
  • BDX $163.33
  • CHTR $382.94
  • Resistance Level
  • BDX $170.49
  • CHTR $408.83
  • Average True Range (ATR)
  • BDX 5.08
  • CHTR 10.84
  • MACD
  • BDX -2.49
  • CHTR 5.08
  • Stochastic Oscillator
  • BDX 8.48
  • CHTR 92.15

About BDX Becton Dickinson and Company

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.

About CHTR Charter Communications Inc. New

Charter is the product of the 2016 merger of three cable companies, each with a decades-long history in the business: Legacy Charter, Time Warner Cable, and Bright House Networks. The firm now holds networks capable of providing television, internet access, and phone services to roughly 57 million US homes and businesses, around 35% of the country. Across this footprint, Charter serves 29 million residential and 2 million commercial customer accounts under the Spectrum brand, making it the second-largest US cable company behind Comcast. The firm also owns, in whole or in part, sports and news networks, including Spectrum SportsNet (long-term local rights to Los Angeles Lakers games), SportsNet LA (Los Angeles Dodgers), SportsNet New York (New York Mets), and Spectrum News NY1.

Share on Social Networks: